Skip to main content
logo
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
13.38
-0.12 (-0.89%)
At close: Sep 17, 2025, 4:00 PM EDT
13.31
-0.07 (-0.52%)
After-hours: Sep 17, 2025, 4:34 PM EDT

KalVista Pharmaceuticals Revenue

KalVista Pharmaceuticals had revenue of $1.43M in the quarter ending July 31, 2025. This brings the company's revenue in the last twelve months to $1.43M.

Revenue (ttm)
$1.43M
Revenue Growth
n/a
P/S Ratio
475.29
Revenue / Employee
$5,281
Employees
270
Market Cap
677.77M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 2025---
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

KALV News

More News